Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis

被引：0
|
作者：
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
机构：
[1] the Sino-US Center for Lymphoma and Leukemia Research,Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Researc
[2] The Ingenuity Centre,Systematic Review Solutions Ltd
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2817 / 2817
相关论文
共 50 条
  • [21] Frontline therapy with Bendamustine and rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma
    Freeman, Ciara Louise
    Savage, Kerry J.
    Villa, Diego
    Scott, David W.
    Gerrie, Alina S.
    Ferguson, David J.
    Cafferty, Fergus
    Slack, Graham W.
    Farinha, Pedro
    Skinnider, Brian
    Connors, Joseph M.
    Sehn, Laurie H.
    BLOOD, 2018, 132
  • [22] Maintenance and consolidation strategies for patients with untreated advanced follicular lymphoma: A systematic review and network meta-analysis of randomized trials
    Chu, Yurou
    Liu, Yingyue
    Yu, Zhuoya
    Zhan, Linquan
    Lu, Tiange
    Jiang, Yujie
    Fang, Xiaosheng
    Zhou, Xiangxiang
    Wang, Xin
    CANCER, 2024, 130 (07) : 1072 - 1082
  • [23] Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies
    Odutola, Michael K.
    Nnakelu, Eriobu
    Giles, Graham G.
    van Leeuwen, Marina T.
    Vajdic, Claire M.
    CANCER CAUSES & CONTROL, 2020, 31 (11) : 979 - 1000
  • [24] Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies
    Michael K. Odutola
    Eriobu Nnakelu
    Graham G. Giles
    Marina T. van Leeuwen
    Claire M. Vajdic
    Cancer Causes & Control, 2020, 31 : 979 - 1000
  • [25] A systematic review and meta-analysis of thalidomide in patients with previously untreated multiple myeloma.
    Hicks, Lisa
    Haynes, Adam
    Reece, Donna E.
    Walker, Irwin
    Herst, Jordan A.
    Imrie, Kevin
    BLOOD, 2006, 108 (11) : 1019A - 1020A
  • [26] Determining the benefits of chemotherapy for achieving complete response in patients with untreated advanced stage follicular lymphoma: A systematic review and meta-analysis.
    Orina, JN
    Moore, SG
    Lechowicz, MJ
    Flowers, CR
    BLOOD, 2005, 106 (11) : 88A - 89A
  • [27] Real-World Treatment Patterns and Outcomes of Patients (Pts) with Follicular Lymphoma (FL) Who Experienced Progression of Disease within 24 Months (POD24)
    Hamid, Muhammad Saad
    Bai, Claire
    Perelgut, Chelsea
    Yelovich, Helena
    Zettler, Christina M.
    Fernandes, Laura L.
    Belli, Andrew J.
    Hansen, Eric
    Wang, Ching-Kun
    BLOOD, 2023, 142
  • [28] SYSTEMATIC REVIEW AND META-ANALYSIS OF INCIDENCE AND RISK FACTORS OF HEPATOCELLULAR CARCINOMA IN UNTREATED HBV INFECTED PATIENTS
    Raffetti, E.
    Fattovich, G.
    Donato, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S447 - S447
  • [29] Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis
    Ting Zhang
    Liang He
    Zhihong Wang
    Wenwu Dong
    Wei Sun
    Ping Zhang
    Hao Zhang
    Endocrine, 2023, 82 : 457 - 466
  • [30] Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis
    Zhang, Ting
    He, Liang
    Wang, Zhihong
    Dong, Wenwu
    Sun, Wei
    Zhang, Ping
    Zhang, Hao
    ENDOCRINE, 2023, 82 (03) : 457 - 466
12345